GHMS yields 3.83% · PFE yields 6.20%● Live data
📍 PFE pulled ahead of the other in Year 9
Combined, GHMS + PFE cover 0 of 12 months — good coverage
Which stock is actually better after tax? Adjust your rate to find out.
What's the optimal mix of GHMS + PFE for your $10,000?
GHMS aims for income by using various proprietary models to invest in fixed income securities including other ETFs. Each fund respectively invests in US and non-US corporate bonds, government securities, and agency and mortgage-backed securities. The underlying ETFs may invest in debt securities of any credit rating or maturity. Utilizing rules-based, quantitative systems in combination with discretionary analysis, the adviser measures market risk to select funds. Adjustments to exposure is based on an analysis supported by proprietary models that may utilize factors, such as momentum and trend, market structure, volatility, cross-asset signals, seasonality, and fundamentals. To hedge duration and interest rate risk, the fund may invest up to 20% of its assets in futures contracts on sovereign bonds or fixed income indexes. The actively managed fund allows the portfolio manager full discretion to adjust the portfolio at any time.
Full GHMS Calculator →Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under the Ibrance, Xtandi, Sutent, Inlyta, Retacrit, Lorbrena, and Braftovi brands; and sterile injectable and anti-infective medicines, and oral COVID-19 treatment under the Sulperazon, Medrol, Zavicefta, Zithromax, Vfend, Panzyga, and Paxlovid brands. The company also provides medicines and vaccines in various therapeutic areas, such as pneumococcal disease, meningococcal disease, tick-borne encephalitis, and COVID-19 under the Comirnaty/BNT162b2, Nimenrix, FSME/IMMUN-TicoVac, Trumenba, and the Prevnar family brands; biosimilars for chronic immune and inflammatory diseases under the Xeljanz, Enbrel, Inflectra, Eucrisa/Staquis, and Cibinqo brands; and amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel/Vyndamax, BeneFIX, and Genotropin brands. In addition, the company is involved in the contract manufacturing business. It serves wholesalers, retailers, hospitals, clinics, government agencies, pharmacies, and individual provider offices, as well as disease control and prevention centers. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Myovant Sciences Ltd.; Akcea Therapeutics, Inc; Merck KGaA; Valneva SE; BioNTech SE; and Arvinas, Inc. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.
Full PFE Calculator →Save your analysis + weekly dividend insights. Free forever.
⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.